MYC and hepatocellular carcinoma: The current study, based on a clear and novel phenotype of transgenic mice, as well as interesting findings in patients, makes c-MYC an attractive target which can help to guide physicians towards preventative strategies and individualized therapy that can improve clinical outcome of MAFLD-related HCC.